News and practice for haematology nurse specialists
The National Institute for Health and Care Excellence has recommended eculizumab (Soliris) for treating a rare life-threatening blood disorder called atypical Haemolytic Uraemic Syndrome (aHUS).
The National Institute for Health and Care Excellence has approved the anti-clotting drug dabigatran (Pradaxa) as an option for treating and preventing deep vein thrombosis and pulmonary embolism.
Latest research: haematology
Bloodborne viruses still pose a risk to health professionals, mainly through sharps-related injuries in the workplace. Increased awareness is needed to reduce this risk.
Chronic kidney disease is irreversible, but management and treatment options are available to help patients self-manage the condition and maintain their quality of life.
Looking for a new career?
Anaemia is often overlooked as its symptoms – shortness of breath, palpitations, headache and dizziness, for example – can be put down to a range of other conditions.